Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial
BMC Endocrine Disorders · 2024
DOI: 10.1186/s12902-024-01692-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Shamasunder Acharya und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hunter New England Health District, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, 2305, Australia. Shamasunder.Acharya@health.nsw.gov…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Delivery of Health Care, Integrated. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Many Australian adults are not receiving timely or effective diabetes management to prevent or delay the onset of diabetes related complications. Integrated care, a worldwide trend in healthcare reform, aims to reduce the fragmented delivery of health services and improve outcomes. This study aimed to test whether a specialist-led integrated model of care provided to a small subset of patients in general practices leads to spillover clinical improvements in all patients of the practice with type 2 diabetes.
Methods
Seventy-two general practice sites (clusters) in New South Wales, Australia received the Diabetes Alliance intervention, creating a non-randomised open cohort stepped wedge trial. The intervention comprised of case conferencing, delivered directly to a small proportion of adults with type 2 diabetes ( n = 1,072) of the general practice sites; as well as practice feedback, education and training. Spillover clinical improvements were assessed on all adults with type 2 diabetes within the general practice sites ( n = 22,706), using practice level data recorded in the MedicineInsight electronic database, compared before and after the intervention. Outcome measures included frequency of diabetes screening tests in line with the Annual Cycle of Care, and clinical results for weight, blood pressure, HbA1c, lipids, and kidney function.
Results
Compared to before Diabetes Alliance, the odds of all practice patients receiving screening tests at or above the recommended intervals were significantly higher for all recommended tests after Diabetes Alliance (odds ratio range 1.41–4.45, p < 0.0001). Significant improvements in clinical outcomes were observed for weight (absolute mean difference: -1.38 kg), blood pressure (systolic − 1.12 mmHg, diastolic − 1.18 mmHg), HbA1c (-0.03% at the mean), total cholesterol (-0.11 mmol/L), and triglycerides (-0.02 mmol/L) ( p < 0.05). There were small but significant declines in kidney function.
Conclusions
Integrated care delivered to a small subset of patients with type 2 diabetes across a large geographic region has spillover benefits that improve the process measures and clinical outcomes for all practice patients with type 2 diabetes.
Trial registration
ACTRN12622001438741; 10th November 2022, retrospectively registered: https://www.anzctr.org.au/ACTRN12622001438741.aspx .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunter New England Health District, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, 2305, Australia. Shamasunder.Acharya@health.nsw.gov.au.
- School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia. Shamasunder.Acharya@health.nsw.gov.au.
- Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia. Shamasunder.Acharya@health.nsw.gov.au.
- School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
- Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.
- Hunter New England Health District, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, 2305, Australia.
Zitieren
APA
Acharya, S., Taylor, R., Parsons, M., Attia, J., Leigh, L., Oldmeadow, C., Wynne, K., Rowe, C., Joseph, M., Luu, J., Philcox, A., Jackel, D., Quach, T., Sankoorikal, C., Dagg, S., & Hure, A. (2024). Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01692-4
Vancouver
Acharya S, Taylor R, Parsons M, Attia J, Leigh L, Oldmeadow C, et al. Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01692-4
BibTeX
@article{Acharya2024,
author = {Acharya, Shamasunder and Taylor, Rachael and Parsons, Martha and Attia, John and Leigh, Lucy and Oldmeadow, Christopher and Wynne, Katie and Rowe, Christopher and Joseph, Morag and Luu, Judy and Philcox, Annalise and Jackel, Damien and Quach, Tuan and Sankoorikal, Christy and Dagg, Simone and Hure, Alexis},
title = {Spillover effects from a type 2 diabetes integrated model of care in 22,706 Australians: an open cohort stepped wedge trial},
journal = {BMC Endocrine Disorders},
year = {2024},
doi = {10.1186/s12902-024-01692-4}
}
EUVIMED